Home ยป
A new type of drug that helps target chemotherapy directly to cancer cells has been found to significantly increase survival of patients with the most common form of bladder cancer, according to results from a
Coronavirus patients treated with a experimental hepatitis drug were FOUR times more likely to have cleared the infection within seven days, study finds Peginterferon-lambda is a man-made form of a naturally occurring protein that calls
The US Senate passed the Comprehensive Immunosuppressive Drug Coverage for Kidney Transplant Patients Act as part of a broad year-end legislative package, extending Medicare coverage of life saving immunosuppressive medications for the life of the
The number of U.S. drug overdose deaths reached a record high as the coronavirus pandemic held the country in its grip last spring, new government data shows. For the 12 months ending in May, more
Pharmaceutical company AstraZeneca says it is buying U.S. drug developer Alexion in a deal worth $39 billion. Cambridge, England-based AstraZeneca PLC, which is involved in one of the efforts to develop a COVID-19 vaccine, said
Dr. Lisa Philp and Professor Colleen Nelson, from the QUT Faculty of Health’s School of Biomedical Science, are developing drugs to fight advanced prostate cancer that could also prevent and or treat acute respiratory distress
TEL AVIV, Israel and RALEIGH, NC, October 14, 2020, RedHill Biopharma Ltd. (Nasdaq: RDHL) (“RedHill” or the “Company”), a specialty biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to
The EU’s medicines regulator on Friday gave the green light for the first injectable treatment for the HIV virus that causes AIDS, which could change the lives of millions of people. The cocktail of two
A new inhalation treatment for preventing the spread of COVID-19 is potentially far more effective than currently existing versions, according to new research carried out at the University of St Andrews. ILC Therapeutics, a Scottish
A drug costing less than 2 euros per dose could reduce the long term consequences of a heart attack, benefitting millions of patients. Metoprolol, a member of the beta-blocker class of drugs that has been